A trial led by Professor Jeremy Chataway (UCL Queen Square Institute of Neurology) and Professor Max Parmar (MRC Clinical Trials Unit at »Ê¼Ò»ªÈË) will combine existing drugs to assess whether drugs already on the market can prevent multiple sclerosis (MS) from worsening over time.